LUIS CARLOS
JIMENEZ ROMERO
Profesor emérito
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (12)
2022
-
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Transplantation, Vol. 106, Núm. 7, pp. 1430-1439
-
Live donor kidney transplantation. Situation analysis and roadmap
Nefrologia, Vol. 42, Núm. 1, pp. 85-93
2020
-
Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients
Nefrologia, Vol. 40, Núm. 3, pp. 265-271
2019
-
Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value – a multi-centre cohort study
Transplant International, Vol. 32, Núm. 3, pp. 313-322
-
Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study
Transplantation Direct, Vol. 5, Núm. 12
2016
-
Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)
Nefrologia, Vol. 36, Núm. 3, pp. 255-267
2015
-
Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus
Transplantation Direct, Vol. 1, Núm. 7, pp. E24
2013
-
A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation
American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500
2012
-
Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: The AnemiaTrans study
Advances in Therapy, Vol. 29, Núm. 11, pp. 979-991
2011
-
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients
American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971
2009
-
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32
2006
-
Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain
Clinical Transplantation, Vol. 20, Núm. 5, pp. 650-658